| In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses Y Itoh, K Shinya, M Kiso, T Watanabe, Y Sakoda, M Hatta, Y Muramoto, ... Nature 460 (7258), 1021-1025, 2009 | 1525 | 2009 |
| Resistant influenza A viruses in children treated with oseltamivir: descriptive study M Kiso, K Mitamura, Y Sakai-Tagawa, K Shiraishi, C Kawakami, K Kimura, ... The Lancet 364 (9436), 759-765, 2004 | 1037 | 2004 |
| Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development M Imai, K Iwatsuki-Horimoto, M Hatta, S Loeber, PJ Halfmann, ... Proceedings of the National Academy of Sciences 117 (28), 16587-16595, 2020 | 991 | 2020 |
| Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors S Yamada, Y Suzuki, T Suzuki, MQ Le, CA Nidom, Y Sakai-Tagawa, ... Nature 444 (7117), 378-382, 2006 | 789 | 2006 |
| Transmission of SARS-CoV-2 in domestic cats PJ Halfmann, M Hatta, S Chiba, T Maemura, S Fan, M Takeda, ... New England Journal of Medicine 383 (6), 592-594, 2020 | 555 | 2020 |
| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 487 | 2022 |
| Characterization of H7N9 influenza A viruses isolated from humans T Watanabe, M Kiso, S Fukuyama, N Nakajima, M Imai, S Yamada, ... Nature 501 (7468), 551-555, 2013 | 460 | 2013 |
| Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variant E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (10), 995-998, 2022 | 361 | 2022 |
| Biological and structural characterization of a host-adapting amino acid in influenza virus S Yamada, M Hatta, BL Staker, S Watanabe, M Imai, K Shinya, ... PLoS pathogens 6 (8), e1001034, 2010 | 353 | 2010 |
| Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense A Kato, Y Sakai, T Shioda, T Kondo, M Nakanishi, Y Nagai Genes to Cells 1 (6), 569-579, 1996 | 349 | 1996 |
| Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA. 2 E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (15), 1475-1477, 2022 | 283 | 2022 |
| Influenza virus-host interactome screen as a platform for antiviral drug development T Watanabe, E Kawakami, JE Shoemaker, TJS Lopes, Y Matsuoka, ... Cell host & microbe 16 (6), 795-805, 2014 | 279 | 2014 |
| Efficacy of antibodies and antiviral drugs against Omicron BA. 2.12. 1, BA. 4, and BA. 5 subvariants E Takashita, S Yamayoshi, V Simon, H Van Bakel, EM Sordillo, A Pekosz, ... New England Journal of Medicine 387 (5), 468-470, 2022 | 271 | 2022 |
| The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis A Kato, K Kiyotani, Y Sakai, T Yoshida, Y Nagai The EMBO journal, 1997 | 269 | 1997 |
| T-705 (favipiravir) activity against lethal H5N1 influenza A viruses M Kiso, K Takahashi, Y Sakai-Tagawa, K Shinya, S Sakabe, QM Le, ... Proceedings of the National Academy of Sciences 107 (2), 882-887, 2010 | 258 | 2010 |
| The anticoagulant nafamostat potently inhibits SARS-CoV-2 S protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner M Yamamoto, M Kiso, Y Sakai-Tagawa, K Iwatsuki-Horimoto, M Imai, ... Viruses 12 (6), 629, 2020 | 245 | 2020 |
| Comparison of rapid antigen tests for COVID-19 S Yamayoshi, Y Sakai-Tagawa, M Koga, O Akasaka, I Nakachi, H Koh, ... Viruses 12 (12), 1420, 2020 | 230 | 2020 |
| Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage T Shioda, H Kato, Y Ohnishi, K Tashiro, M Ikegawa, EE Nakayama, H Hu, ... Proceedings of the National Academy of Sciences 95 (11), 6331-6336, 1998 | 221 | 1998 |
| Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA. 2 R Uraki, M Kiso, S Iida, M Imai, E Takashita, M Kuroda, PJ Halfmann, ... Nature 607 (7917), 119-127, 2022 | 217 | 2022 |
| Enhanced expression of an α2, 6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor S Hatakeyama, Y Sakai-Tagawa, M Kiso, H Goto, C Kawakami, ... Journal of clinical microbiology 43 (8), 4139-4146, 2005 | 201 | 2005 |
